Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06519955 · ClinicalTrials.gov registry record · Phase 2

Can PLIA Reduce Early Post-operative Pain After PAO Surgery?

A Phase 2 study of Hip Dysplasia, sponsored by Michael C Willey.

Recruiting
Registry status
Phase 2
Development phase
120
Enrollment target
1
Study location

NCT06519955 is a Phase 2 study of Hip Dysplasia that is actively recruiting participants, run by Michael C Willey. The registered enrollment target is 120 participants, below the 183-participant average among 5 other Hip Dysplasia trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06519955, a Phase 2 study of Hip Dysplasia, is actively recruiting participants, sponsored by Michael C Willey.

RECRUITING
Registry status
Phase 2
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to compare different peri-incisional local infiltrative anesthesia (PLIA) methods in patients ages 13 to 50 undergoing a periacetabular osteotomy (PAO). The main questions to answer here are: 1. Does PLIA impact post-operative pain after PAO? 2. Does PLIA impact pain medication usage as measured by morphine equivalent dosing (MED) after PAO? 3. Does the timing of PLIA administration impact post-operative pain and MED after PAO? Participants will be asked to complete some surveys; demographics survey, General Self-Efficacy Scale (GSE) and the Pain Resilience Scale. All other information will be gathered from the patients medical chart. Researchers will compare three groups. 1.) Patients who do not receive PLIA. 2.) Patients who receive PLIA after their incision is closed. 3.) Patients who receive PLIA throughout PAO.

Conditions Studied

Interventions

  • COMBINATION_PRODUCT Ropivacaine, Epinephrine, Ketorolac, NaCl (Saline)

Study Locations (1)

Iowa

  • University of Iowa Health Care - Iowa City

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2024-10-03
Est. Completion 2026-09
Phase Phase 2

Sponsor

Michael C Willey

4 total trials

What the Registry Record Tells You About NCT06519955

The ClinicalTrials.gov registry entry for NCT06519955 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 5 other Hip Dysplasia trials with a reported enrollment target (34% lower). The listed sponsor is Michael C Willey, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hip Dysplasia appearing as the primary indexed condition, and to 1 intervention - of which Ropivacaine, Epinephrine, Ketorolac, NaCl (Saline) is the first listed.

NCT06519955 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT06519955 about?

NCT06519955 is a clinical study titled "Can PLIA Reduce Early Post-operative Pain After PAO Surgery?". The goal of this clinical trial is to compare different peri-incisional local infiltrative anesthesia (PLIA) methods in patients ages 13 to 50 undergoing a periacetabular osteotomy (PAO). The main questions to answer here are: 1. Does PLIA impact post-operative pain after PAO? 2. Does PLIA impact p...

What is the current status of trial NCT06519955?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2024-10-03. Estimated completion is 2026-09.

What conditions does trial NCT06519955 study?

This clinical trial studies the following conditions: Hip Dysplasia.

What interventions are being tested in trial NCT06519955?

The interventions under investigation include: Ropivacaine, Epinephrine, Ketorolac, NaCl (Saline) (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT06519955?

This trial is sponsored by Michael C Willey, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06519955 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Dysplasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.